Mohamed A Kurer
Overview
Explore the profile of Mohamed A Kurer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
129
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Aleter A, Taha R, Khawar M, Yousif M, Kurer M
Cureus
. 2024 Aug;
16(7):e65688.
PMID: 39205732
Intestinal malrotation is an infrequent congenital anomaly. Its presentation in adults is rare, and it is usually discovered incidentally. This article presents an extremely rare case of an adult patient...
2.
Al Dhaheri M, Mubarak R, Kurer M
Dis Colon Rectum
. 2023 Aug;
67(1):e9.
PMID: 37610474
No abstract available.
3.
Toor S, Sasidharan Nair V, Saleh R, Taha R, Murshed K, Al-Dhaheri M, et al.
Vaccines (Basel)
. 2021 Apr;
9(4).
PMID: 33916009
Colorectal cancer (CRC) is influenced by infiltration of immune cell populations in the tumor microenvironment. While elevated levels of cytotoxic T cells are associated with improved prognosis, limited studies have...
4.
Sasidharan Nair V, Saleh R, Toor S, Taha R, Ahmed A, Kurer M, et al.
Epigenomics
. 2020 Nov;
12(21):1871-1882.
PMID: 33169618
To elucidate the epigenetic alterations behind the upregulation of immune checkpoints and T cell exhaustion markers in colorectal cancer (CRC) patients. mRNA expressions of different immune checkpoint/exhaustion markers were analyzed...
5.
Sasidharan Nair V, Saleh R, Taha R, Toor S, Murshed K, Ahmed A, et al.
Oncoimmunology
. 2020 Oct;
9(1):1825178.
PMID: 33101776
Tumor-infiltrating lymphocytes (TILs) play indispensable roles in the progression and response to treatment of solid tumors. However, the prognostic significance of CD4 TILs is not fully disclosed in cancers generally...
6.
Khalaf S, Toor S, Murshed K, Kurer M, Ahmed A, Nada M, et al.
Clin Immunol
. 2020 Apr;
215:108429.
PMID: 32320745
T-cell immunoglobulin and mucin-domain containing-3 (TIM-3) is an inhibitory immune checkpoint, which suppresses anti-tumor immune responses. TIM-3 expression on different immune cells in periphery and tumor microenvironment (TME) of colorectal...
7.
Sasidharan Nair V, Toor S, Taha R, Ahmed A, Kurer M, Murshed K, et al.
Vaccines (Basel)
. 2020 Feb;
8(1).
PMID: 32041340
T cell immunoglobulin mucin-3 (TIM-3) is an immune checkpoint identified as one of the key players in regulating T-cell responses. Studies have shown that TIM-3 is upregulated in the tumor...
8.
Sasidharan Nair V, Saleh R, Toor S, Taha R, Ahmed A, Kurer M, et al.
Clin Epigenetics
. 2020 Jan;
12(1):13.
PMID: 31941522
Background: Increased numbers of myeloid-derived suppressor cells (MDSCs) are positively correlated with poor prognosis and reduced survivals of cancer patients. They play central roles in tumor immune evasion and tumor...
9.
10.
Mosley F, Shahi N, Kurer M
JSLS
. 2013 Mar;
16(2):236-41.
PMID: 23477171
Background: Intrauterine contraceptive devices (IUCDs) comprise the most popular form of reversible contraception. Uterine perforation is a rare but potentially serious complication associated with their use. We examined all reported...